15/02/2026
One Injection. Long-Term BP Control.
💉 Zilebesiran Injection – A New Era in Hypertension Treatment
🧬 Zilebesiran is an innovative RNA interference (siRNA)–based injection designed for long-term blood pressure control.
💉 How it works:
It targets angiotensinogen in the liver, leading to sustained suppression of the renin–angiotensin system → powerful and long-lasting BP reduction.
⏳ Key highlights:
✔️ Given as infrequent subcutaneous injections (every few months)
✔️ Provides consistent BP control
✔️ Useful for patients with poor adherence to daily tablets
✔️ Potential future option for resistant hypertension
🌍 Current status: Still under clinical trials — not yet widely available, but very promising.
📌 A glimpse into the future of hypertension management: fewer pills, better control.
Reference
1. Zilebesiran – Wikipedia (overview and mechanism)
https://en.wikipedia.org/wiki/Zilebesiran 
2. Roche & Alnylam press release on Zilebesiran development
https://www.roche.com/media/releases/med-cor-2023-07-24 
